BACKGROUND: Aspiration of gastroesophageal refluxate has been implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF) and the progression of bronchiolitis obliterans syndrome after lung transplantation. The goals of the present study were to identify lung transplant patients at the greatest risk of aspiration and to investigate the causative factors. MATERIALS AND METHODS: From September 2009 to November 2011, 252 bronchoalveolar lavage fluid (BALF) samples were collected from 100 lung transplant patients. The BALF pepsin concentrations and the results of transbronchial biopsy, esophageal function testing, barium swallow, and gastric emptying scan were compared among those with the most common end-stage lung diseases requiring lung transplantation: IPF, chronic obstructive pulmonary disease, cystic fibrosis, and α1-antitrypsin deficiency. RESULTS: Patients with IPF had higher BALF pepsin concentrations and a greater frequency of acute rejection than those with α1-antitrypsin deficiency, cystic fibrosis, or chronic obstructive pulmonary disease (P = 0.037). Moreover, the BALF pepsin concentrations correlated negatively with a lower esophageal sphincter pressure and distal esophageal amplitude; negatively with distal esophageal amplitude and positively with total esophageal acid time, longest reflux episode, and DeMeester score in those with chronic obstructive pulmonary disease; and negatively with the upright acid clearance time in those with IPF. CONCLUSIONS: Our results suggest that patients with IPF after lung transplantation are at increased risk of aspiration and a greater frequency of acute rejection episodes, and that the risk factors for aspiration might be different among those with the most common end-stage lung diseases who have undergone lung transplantation. These results support the role of evaluating the BALF for markers of aspiration in assessing lung transplant patients as candidates for antireflux surgery.
BACKGROUND: Aspiration of gastroesophageal refluxate has been implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF) and the progression of bronchiolitis obliterans syndrome after lung transplantation. The goals of the present study were to identify lung transplant patients at the greatest risk of aspiration and to investigate the causative factors. MATERIALS AND METHODS: From September 2009 to November 2011, 252 bronchoalveolar lavage fluid (BALF) samples were collected from 100 lung transplant patients. The BALF pepsin concentrations and the results of transbronchial biopsy, esophageal function testing, barium swallow, and gastric emptying scan were compared among those with the most common end-stage lung diseases requiring lung transplantation: IPF, chronic obstructive pulmonary disease, cystic fibrosis, and α1-antitrypsin deficiency. RESULTS:Patients with IPF had higher BALF pepsin concentrations and a greater frequency of acute rejection than those with α1-antitrypsin deficiency, cystic fibrosis, or chronic obstructive pulmonary disease (P = 0.037). Moreover, the BALF pepsin concentrations correlated negatively with a lower esophageal sphincter pressure and distal esophageal amplitude; negatively with distal esophageal amplitude and positively with total esophageal acid time, longest reflux episode, and DeMeester score in those with chronic obstructive pulmonary disease; and negatively with the upright acid clearance time in those with IPF. CONCLUSIONS: Our results suggest that patients with IPF after lung transplantation are at increased risk of aspiration and a greater frequency of acute rejection episodes, and that the risk factors for aspiration might be different among those with the most common end-stage lung diseases who have undergone lung transplantation. These results support the role of evaluating the BALF for markers of aspiration in assessing lung transplant patients as candidates for antireflux surgery.
Authors: Marc Estenne; Janet R Maurer; Annette Boehler; James J Egan; Adaani Frost; Marshall Hertz; George B Mallory; Gregory I Snell; Samuel Yousem Journal: J Heart Lung Transplant Date: 2002-03 Impact factor: 10.247
Authors: David C Neujahr; Aminu Mohammed; Onome Ulukpo; Seth D Force; Allan M Ramirez; Andres Pelaez; E Clinton Lawrence; Christian P Larsen; Allan D Kirk Journal: Chest Date: 2010-06-03 Impact factor: 9.410
Authors: Frank D'Ovidio; Marco Mura; Melanie Tsang; Thomas K Waddell; Michael A Hutcheon; Lianne G Singer; Denis Hadjiliadis; Cecilia Chaparro; Carlos Gutierrez; Andrew Pierre; Gail Darling; Mingyao Liu; Shaf Keshavjee Journal: J Thorac Cardiovasc Surg Date: 2005-05 Impact factor: 5.209
Authors: Denis Hadjiliadis; R Duane Davis; Mark P Steele; Robert H Messier; Christine L Lau; Steve S Eubanks; Scott M Palmer Journal: Clin Transplant Date: 2003-08 Impact factor: 2.863
Authors: Edward Cantu; James Z Appel; Matthew G Hartwig; Hiwot Woreta; Cindy Green; Robert Messier; Scott M Palmer; R Duane Davis Journal: Ann Thorac Surg Date: 2004-10 Impact factor: 4.330
Authors: R Duane Davis; Christine L Lau; Steve Eubanks; Robert H Messier; Denis Hadjiliadis; Mark P Steele; Scott M Palmer Journal: J Thorac Cardiovasc Surg Date: 2003-03 Impact factor: 5.209
Authors: Marco E Allaix; Fabrizio Rebecchi; Mario Morino; Francisco Schlottmann; Marco G Patti Journal: World J Surg Date: 2017-07 Impact factor: 3.352
Authors: Misbah Baqir; Amit Vasirreddy; Ann N Vu; Teng Moua; Alanna M Chamberlain; Ryan D Frank; Jay H Ryu Journal: Respir Med Date: 2021-01-22 Impact factor: 4.582
Authors: Anupong Tangaroonsanti; Augustine S Lee; Michael D Crowell; Marcelo F Vela; Daryl R Jones; David Erasmus; Cesar Keller; Jorge Mallea; Francisco Alvarez; Cristina Almansa; Kenneth R DeVault; Lesley A Houghton Journal: Clin Transl Gastroenterol Date: 2017-06-29 Impact factor: 4.488
Authors: Chang Min Lee; Dong Ho Lee; Byung Kyu Ahn; Jae Jin Hwang; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Nayoung Kim Journal: J Neurogastroenterol Motil Date: 2016-07-30 Impact factor: 4.924